SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 129 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $612,000 | +83.2% | 43,470 | -3.0% | 0.00% | +100.0% |
Q2 2017 | $334,000 | -12.1% | 44,811 | -23.3% | 0.00% | -50.0% |
Q1 2017 | $380,000 | +27.9% | 58,436 | -13.0% | 0.00% | +100.0% |
Q4 2016 | $297,000 | +4.9% | 67,152 | +10.9% | 0.00% | 0.0% |
Q3 2016 | $283,000 | -58.8% | 60,530 | -42.1% | 0.00% | -66.7% |
Q2 2016 | $687,000 | +127.5% | 104,516 | +120.0% | 0.00% | +200.0% |
Q1 2016 | $302,000 | +14.0% | 47,499 | +8.1% | 0.00% | 0.0% |
Q4 2015 | $265,000 | +2.7% | 43,935 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $258,000 | -12.5% | 43,123 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $295,000 | -67.7% | 43,123 | -71.3% | 0.00% | -75.0% |
Q1 2015 | $912,000 | -11.8% | 150,189 | +0.7% | 0.00% | 0.0% |
Q4 2014 | $1,034,000 | -7.9% | 149,163 | +8.2% | 0.00% | -20.0% |
Q3 2014 | $1,123,000 | +175.9% | 137,921 | +175.6% | 0.01% | +150.0% |
Q2 2014 | $407,000 | +5.7% | 50,036 | +2.0% | 0.00% | 0.0% |
Q1 2014 | $385,000 | -11.3% | 49,054 | +0.0% | 0.00% | 0.0% |
Q4 2013 | $434,000 | +2.4% | 49,042 | -2.9% | 0.00% | 0.0% |
Q3 2013 | $424,000 | +26.2% | 50,501 | +12.3% | 0.00% | 0.0% |
Q2 2013 | $336,000 | – | 44,985 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |